Oxidative stress leading to higher levels of reactive oxygen species (ROS) is a common hallmark of cancer cells, which can stimulate cellular proliferation and cause cellular injury.
Parthenolide decreases radiation-induced ROS in normal prostate epithelial cells, suggesting that the intracellular redox status maybe a way to achieve selective drug targeting [163].